Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_assertion type Assertion NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_head.
- NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_assertion wasGeneratedBy ECO_0000203 NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_provenance.
- NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_assertion wasDerivedFrom befree-2016 NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_provenance.
- NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_assertion SIO_000772 24627085 NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_provenance.
- NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_assertion evidence source_evidence_literature NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_provenance.
- NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_assertion description "[The veliparib and CPT-11 combination can be further explored as a treatment of metastatic castration-resistant prostate cancers that have frequent p53 mutations and enriched genomic instability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1163696.RAWsBUx5RYHeOOHMqcsGfimHHJ1uTGb5qDJbZr7TjyO80130_provenance.